On 12 February, 30 of Europe’s top life science start-ups and scale-ups had the opportunity to present their projects to three different panels of investors. The investor panels selected 9 companies for the 13 February start-up pitching competition in the program of the main I4H conference. Leading European venture capital companies such as INKEF Capital, Medicxi or SkylineDx & Van Herk Investments were part of the investor panel.
We were selected as one of the top three companies and were only outperformed by the local Dutch biotech company PharmaCytics. A great achievement with the support of Business France and Medicen Paris !